Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29299590.
- Also identified by DOI 10.1001/jamadermatol.2017.5176 and PMC identifier 5885811.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case-series study of 11 patients with severe, difficult-to-treat pemphigus examines whether rituximab alone can be used long-term as maintenance therapy for prevention of relapse.
Medical subject headings
- Immunologic Factors
- Pemphigus
- Rituximab